GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYVE.L Regulatory News (HYVE)

  • There is currently no data for HYVE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Hyve Group Plc

6 Mar 2023 12:02

Form 8.3 - Hyve Group Plc

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Jupiter Fund Management Plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeHyve Group plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure3rd March 2023
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:10p Ordinary
 InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled:13,097,8374.49  
(2) Cash-settled derivatives:    
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:13,097,8374.49  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:None
Details, including nature of the rights concerned and relevant percentages:None

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
10p OrdinarySale854,1411.02

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
NONE    
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
NONE       

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
NONE    

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
    

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:6th March 2023
Contact name:Claire Rodway
Telephone number:0203 817 1441

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
9th Mar 20222:09 pmRNSHolding(s) in Company
7th Mar 20224:27 pmRNSHolding(s) in Company
3rd Mar 20229:55 amRNSHolding(s) in Company
3rd Mar 20227:00 amRNSDirector/PDMR Shareholding
2nd Mar 202212:23 pmRNSDirector/PDMR Shareholding
1st Mar 20221:41 pmRNSHolding(s) in Company
28th Feb 20224:21 pmRNSHolding(s) in Company
28th Feb 20221:24 pmRNSResponse to the Russia/Ukraine conflict
28th Feb 202211:06 amRNSHolding(s) in Company
11th Feb 202212:50 pmRNSHolding(s) in Company
3rd Feb 20229:50 amRNSAnnouncement of Results of Annual General Meeting
3rd Feb 20227:00 amRNSBoard Changes
3rd Feb 20227:00 amRNSTrading Update
26th Jan 20222:50 pmRNSHolding(s) in Company
11th Jan 20229:33 amRNSHolding(s) in Company
5th Jan 202211:09 amRNSPublication of Annual Report and Notice of AGM
20th Dec 20213:17 pmRNSDirector/PDMR Shareholding
16th Dec 20217:00 amRNSFY21 Preliminary Results
1st Dec 20217:00 amRNSVoting Rights and Capital
24th Nov 20215:17 pmRNSHolding(s) in Company
23rd Nov 20214:16 pmRNSHolding(s) in Company
23rd Nov 20211:59 pmRNSHolding(s) in Company
18th Nov 20211:54 pmRNSDirector/PDMR Shareholding
18th Nov 20219:41 amRNSAcquisition of 121 Group & Agreement with Lenders
18th Nov 20217:00 amRNSAcquisition of 121 Group & Agreement with Lenders
18th Nov 20217:00 amRNSProposed placing and direct subscription
11th Nov 20215:48 pmRNSCorrection - Director/PDMR Shareholding
26th Oct 20212:54 pmRNSDirector/PDMR Shareholding
25th Oct 202111:26 amRNSAnnouncement of Results of General Meeting
13th Oct 20211:16 pmRNSDirector Declaration
8th Oct 20219:28 amRNSNotice of General Meeting
7th Oct 20217:00 amRNSPre-close trading update
1st Oct 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Aug 20213:26 pmRNSHolding(s) in Company
20th Jul 20215:13 pmRNSHolding(s) in Company
13th Jul 20214:34 pmRNSHolding(s) in Company
8th Jul 20217:00 amRNSTrading Update
24th Jun 202110:38 amRNSHolding(s) in Company
23rd Jun 20219:13 amRNSHolding(s) in Company
1st Jun 20217:00 amRNSResponse to recent press speculation
28th May 202111:48 amRNSHolding(s) in Company
26th May 202111:09 amRNSHolding(s) in Company
18th May 20217:00 amRNSInterim Results
11th May 20212:16 pmRNSHolding(s) in Company
26th Apr 202112:44 pmRNSHolding(s) in Company
23rd Apr 20214:08 pmRNSHolding(s) in Company
8th Apr 20217:00 amRNSTrading Update
1st Apr 202110:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
24th Mar 202111:50 amRNSHolding(s) in Company
22nd Feb 20212:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.